Clinical trial
Phase II Clinical Trial Evaluating the Safety and Efficacy of a Tissue Engineered Autologous Skin Substitute Reconstructive Surgery for Basal Cell Carcinoma
NCT05234658 is registered in ClinicalTrials.gov with Andalusian Network for Design and Translation of Advanced Therapies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Clinical Trial Evaluating the Safety and Efficacy of a Tissue Engineered Autologous Skin Substitute Reconstructive Surgery for Basal Cell Carcinoma
- Lead sponsor
- Andalusian Network for Design and Translation of Advanced Therapies
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 21, 2022
- Completion date
- December 1, 2024
- Enrollment
- 21 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.